{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T02:38:30Z","timestamp":1790217510223,"version":"4.1.0"},"reference-count":109,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T00:00:00Z","timestamp":1662336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007195","name":"Universit\u00e0 degli Studi di Napoli Federico II","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Obes Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose of Review<\/jats:title>\n                <jats:p>Prader\u2013Willi syndrome (PWS) is a rare and complex genetic disorder with multiple effects on the metabolic, endocrine, and neurological systems, as well as behavioral and intellectual difficulties. Despite advances in understanding the genetic basis of obesity in PWS, there are conflicting data on its management. Therefore, the present manuscript aims to provide an update on the nutritional treatment and pharmacological approach in adult patients with PWS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Recent Findings<\/jats:title>\n                <jats:p>The management of obesity in patients with PWS is challenging and requires the cooperation of an experienced multidisciplinary team, including the nutritionist. An adequate clinical evaluation including nutritional and biochemical parameters should be performed to tailor the best therapeutic strategy. Both lifestyle and pharmacological interventions may represent useful strategies to prevent the high rate of morbidity and mortality related to PWS. The use of bariatric surgery is still controversial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Summary<\/jats:title>\n                <jats:p>Although it is imperative to adopt an obesity prevention strategy in childhood, there is promising evidence for the treatment of obesity in adulthood with current obesity medications in conjunction with lifestyle interventions<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s13679-022-00478-w","type":"journal-article","created":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T04:02:37Z","timestamp":1662350557000},"page":"263-276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Prader\u2013Willi Syndrome in Adults: An Update On Nutritional Treatment and Pharmacological Approach"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-456X","authenticated-orcid":false,"given":"Luigi","family":"Barrea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Vetrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"de Alteriis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Maria","family":"Panfili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Bocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Verde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Savastano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Muscogiuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,5]]},"reference":[{"issue":"12","key":"478_CR1","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38(12):1249\u201363. https:\/\/doi.org\/10.1007\/s40618-015-0312-9.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"478_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ. Prader-Willi syndrome. Genet Med. 2012;14(1):10\u201326. https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0.","journal-title":"Genet Med"},{"issue":"11","key":"478_CR3","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/ajmg.a.40491","volume":"176","author":"ML Mackenzie","year":"2018","unstructured":"Mackenzie ML, Triador L, Gill JK, et al. Dietary intake in youth with prader-willi syndrome. Am J Med Genet A. 2018;176(11):2309\u201317. https:\/\/doi.org\/10.1002\/ajmg.a.40491.","journal-title":"Am J Med Genet A"},{"issue":"9","key":"478_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.endinu.2019.03.004","volume":"66","author":"M Guinovart","year":"2019","unstructured":"Guinovart M, Coronas R, Caixas A. Psychopathological disorders in Prader-Willi syndrome. Endocrinol Diabetes Nutr (Engl Ed). 2019;66(9):579\u201387. https:\/\/doi.org\/10.1016\/j.endinu.2019.03.004.","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"issue":"10","key":"478_CR5","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1007\/s40618-021-01574-9","volume":"44","author":"G Muscogiuri","year":"2021","unstructured":"Muscogiuri G, Barrea L, Faggiano F, et al. Obesity in Prader-Willi syndrome: physiopathological mechanisms, nutritional and pharmacological approaches. J Endocrinol Invest. 2021;44(10):2057\u201370. https:\/\/doi.org\/10.1007\/s40618-021-01574-9.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"478_CR6","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3945\/an.117.016253","volume":"8","author":"M Alsaif","year":"2017","unstructured":"Alsaif M, Elliot SA, MacKenzie ML, Prado CM, Field CJ, Haqq AM. Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review. Adv Nutr. 2017;8(6):905\u201315. https:\/\/doi.org\/10.3945\/an.117.016253.","journal-title":"Adv Nutr"},{"key":"478_CR7","doi-asserted-by":"publisher","unstructured":"Krasinska A, Skowronska B. Prader-Willi Syndrome - nutritional management in children, adolescents and adults. Pediatr Endocrinol Diabetes Metab. 2017;23(2):101\u2013106. https:\/\/doi.org\/10.18544\/PEDM-23.02.0080.","DOI":"10.18544\/PEDM-23.02.0080"},{"issue":"3","key":"478_CR8","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1067\/S0022-3476(03)00386-X","volume":"143","author":"MT Bekx","year":"2003","unstructured":"Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB. Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr. 2003;143(3):372\u20136. https:\/\/doi.org\/10.1067\/S0022-3476(03)00386-X.","journal-title":"J Pediatr"},{"issue":"12","key":"478_CR9","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/ijo.2011.274","volume":"36","author":"AP Goldstone","year":"2012","unstructured":"Goldstone AP, Holland AJ, Butler JV, Whittington JE. Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome. Int J Obes (Lond). 2012;36(12):1564\u201370. https:\/\/doi.org\/10.1038\/ijo.2011.274.","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"478_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1687-9856-2013-14","volume":"2013","author":"JE Emerick","year":"2013","unstructured":"Emerick JE, Vogt KS. Endocrine manifestations and management of Prader-Willi syndrome. Int J Pediatr Endocrinol. 2013;2013(1):14. https:\/\/doi.org\/10.1186\/1687-9856-2013-14.","journal-title":"Int J Pediatr Endocrinol"},{"key":"478_CR11","doi-asserted-by":"publisher","unstructured":"Noordam C, Hoybye C, Eiholzer U. Prader-Willi Syndrome and Hypogonadism: A Review Article. Int J Mol Sci. 2021;22(5). https:\/\/doi.org\/10.3390\/ijms22052705.","DOI":"10.3390\/ijms22052705"},{"issue":"15","key":"478_CR12","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1093\/hmg\/ddv159","volume":"24","author":"I Pravdivyi","year":"2015","unstructured":"Pravdivyi I, Ballanyi K, Colmers WF, Wevrick R. Progressive postnatal decline in leptin sensitivity of arcuate hypothalamic neurons in the Magel2-null mouse model of Prader-Willi syndrome. Hum Mol Genet. 2015;24(15):4276\u201383. https:\/\/doi.org\/10.1093\/hmg\/ddv159.","journal-title":"Hum Mol Genet"},{"issue":"6","key":"478_CR13","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","volume":"98","author":"CL Deal","year":"2013","unstructured":"Deal CL, Tony M, Hoybye C, et al. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98(6):E1072-1087. https:\/\/doi.org\/10.1210\/jc.2012-3888.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"478_CR14","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/ajmg.a.60688","volume":"179","author":"J Proffitt","year":"2019","unstructured":"Proffitt J, Osann K, McManus B, et al. Contributing factors of mortality in Prader-Willi syndrome. Am J Med Genet A. 2019;179(2):196\u2013205. https:\/\/doi.org\/10.1002\/ajmg.a.60688.","journal-title":"Am J Med Genet A"},{"issue":"2","key":"478_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11892-020-1284-5","volume":"20","author":"A Crino","year":"2020","unstructured":"Crino A, Grugni G. Update on Diabetes Mellitus and Glucose Metabolism Alterations in Prader-Willi Syndrome. Curr Diab Rep. 2020;20(2):7. https:\/\/doi.org\/10.1007\/s11892-020-1284-5.","journal-title":"Curr Diab Rep"},{"issue":"1","key":"478_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmg.2021.104379","volume":"65","author":"SA Bellis","year":"2022","unstructured":"Bellis SA, Kuhn I, Adams S, Mullarkey L, Holland A. The consequences of hyperphagia in people with Prader-Willi Syndrome: A systematic review of studies of morbidity and mortality. Eur J Med Genet. 2022;65(1): 104379. https:\/\/doi.org\/10.1016\/j.ejmg.2021.104379.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"478_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000313377","volume":"74","author":"G Diene","year":"2010","unstructured":"Diene G, Mimoun E, Feigerlova E, et al. Endocrine disorders in children with Prader-Willi syndrome\u2013data from 142 children of the French database. Horm Res Paediatr. 2010;74(2):121\u20138. https:\/\/doi.org\/10.1159\/000313377.","journal-title":"Horm Res Paediatr"},{"key":"478_CR18","doi-asserted-by":"publisher","unstructured":"Sinnema M, Maaskant MA, van Schrojenstein Lantman-de Valk HM, et al. Physical health problems in adults with Prader-Willi syndrome. Am J Med Genet A. 2011;155A(9):2112\u20132124. https:\/\/doi.org\/10.1002\/ajmg.a.34171.","DOI":"10.1002\/ajmg.a.34171"},{"issue":"1\u20132","key":"478_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1515\/jpem-2013-0116","volume":"27","author":"JL Miller","year":"2014","unstructured":"Miller JL, Linville TD, Dykens EM. Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study. J Pediatr Endocrinol Metab. 2014;27(1\u20132):23\u20139. https:\/\/doi.org\/10.1515\/jpem-2013-0116.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"478_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejmg.2010.09.015","volume":"54","author":"R Motaghedi","year":"2011","unstructured":"Motaghedi R, Lipman EG, Hogg JE, Christos PJ, Vogiatzi MG, Angulo MA. Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome. Eur J Med Genet. 2011;54(1):14\u20138. https:\/\/doi.org\/10.1016\/j.ejmg.2010.09.015.","journal-title":"Eur J Med Genet"},{"issue":"9555","key":"478_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0140-6736(07)60033-6","volume":"369","author":"RS Padwal","year":"2007","unstructured":"Padwal RS, Majumdar SR. Drug treatments for obesity: orlistat, sibutramine, and rimonabant. Lancet. 2007;369(9555):71\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(07)60033-6.","journal-title":"Lancet"},{"issue":"9","key":"478_CR22","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1089\/cap.2016.0073","volume":"26","author":"A Hor","year":"2016","unstructured":"Hor A, Purtell L.Influence of Naltrexone, Bupropion Combination Treatment on Body Mass Index in Prader-Willi Syndrome Re: \u201cPrader-Willi Syndrome, Management of Impulsivity, and Hyperphagia in an Adolescent\u201d by Puri, et al. J Child Adolesc Psychopharmacol. 2016;26(9):854. https:\/\/doi.org\/10.1089\/cap.2016.0073.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"478_CR23","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.2337\/dc13-2575","volume":"37","author":"D Fintini","year":"2014","unstructured":"Fintini D, Grugni G, Brufani C, Bocchini S, Cappa M, Crino A. Use of GLP-1 receptor agonists in Prader-Willi Syndrome: report of six cases. Diabetes Care. 2014;37(4):e76-77. https:\/\/doi.org\/10.2337\/dc13-2575.","journal-title":"Diabetes Care"},{"issue":"5","key":"478_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12992","volume":"21","author":"Q Tan","year":"2020","unstructured":"Tan Q, Orsso CE, Deehan EC, et al. Current and emerging therapies for managing hyperphagia and obesity in Prader-Willi syndrome: A narrative review. Obes Rev. 2020;21(5): e12992. https:\/\/doi.org\/10.1111\/obr.12992.","journal-title":"Obes Rev"},{"issue":"2","key":"478_CR25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11154-019-09502-2","volume":"20","author":"G Muscogiuri","year":"2019","unstructured":"Muscogiuri G, Formoso G, Pugliese G, et al. Prader- Willi syndrome: An uptodate on endocrine and metabolic complications. Rev Endocr Metab Disord. 2019;20(2):239\u201350. https:\/\/doi.org\/10.1007\/s11154-019-09502-2.","journal-title":"Rev Endocr Metab Disord"},{"issue":"1","key":"478_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s11689-021-09373-2","volume":"13","author":"L Schwartz","year":"2021","unstructured":"Schwartz L, Caixas A, Dimitropoulos A, et al. Behavioral features in Prader-Willi syndrome (PWS): consensus paper from the International PWS Clinical Trial Consortium. J Neurodev Disord. 2021;13(1):25. https:\/\/doi.org\/10.1186\/s11689-021-09373-2.","journal-title":"J Neurodev Disord"},{"issue":"5","key":"478_CR27","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","volume":"155A","author":"JL Miller","year":"2011","unstructured":"Miller JL, Lynn CH, Driscoll DC, et al. Nutritional phases in Prader-Willi syndrome. Am J Med Genet A. 2011;155A(5):1040\u20139. https:\/\/doi.org\/10.1002\/ajmg.a.33951.","journal-title":"Am J Med Genet A"},{"issue":"1","key":"478_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13023-020-01440-6","volume":"15","author":"L Damen","year":"2020","unstructured":"Damen L, Donze SH, Kuppens RJ, et al. Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition. Orphanet J Rare Dis. 2020;15(1):163. https:\/\/doi.org\/10.1186\/s13023-020-01440-6.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"478_CR29","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/jc.2014-3127","volume":"100","author":"D Lacroix","year":"2015","unstructured":"Lacroix D, Moutel S, Coupaye M, et al. Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. J Clin Endocrinol Metab. 2015;100(3):850\u20139. https:\/\/doi.org\/10.1210\/jc.2014-3127.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"478_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.a.35653","volume":"161A","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Abe Y, Oto Y, et al. Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet A. 2013;161A(1):27\u201333. https:\/\/doi.org\/10.1002\/ajmg.a.35653.","journal-title":"Am J Med Genet A"},{"key":"478_CR31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/DMSO.S141352","volume":"11","author":"A Crino","year":"2018","unstructured":"Crino A, Fintini D, Bocchini S, Grugni G. Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes. 2018;11:579\u201393. https:\/\/doi.org\/10.2147\/DMSO.S141352.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"10","key":"478_CR32","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/ijo.2017.139","volume":"41","author":"E Hedgeman","year":"2017","unstructured":"Hedgeman E, Ulrichsen SP, Carter S, et al. Long-term health outcomes in patients with Prader-Willi Syndrome: a nationwide cohort study in Denmark. Int J Obes (Lond). 2017;41(10):1531\u20138. https:\/\/doi.org\/10.1038\/ijo.2017.139.","journal-title":"Int J Obes (Lond)"},{"key":"478_CR33","doi-asserted-by":"publisher","unstructured":"Goldstone AP, Holland AJ, Hauffa BP, Hokken-Koelega AC, Tauber M, speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93(11):4183\u20134197. https:\/\/doi.org\/10.1210\/jc.2008-0649.","DOI":"10.1210\/jc.2008-0649"},{"key":"478_CR34","doi-asserted-by":"publisher","unstructured":"Pellikaan K, Rosenberg AGW, Kattentidt-Mouravieva AA, et al. Missed Diagnoses and Health Problems in Adults With Prader-Willi Syndrome: Recommendations for Screening and Treatment. J Clin Endocrinol Metab. 2020;105(12). https:\/\/doi.org\/10.1210\/clinem\/dgaa621.","DOI":"10.1210\/clinem\/dgaa621"},{"issue":"1","key":"478_CR35","first-page":"23","volume":"4","author":"MG Butler","year":"1990","unstructured":"Butler MG, Swift LL, Hill JO. Fasting Plasma Lipid, Glucose, and Insulin Levels in Prader-Willi Syndrome and Obese Individuals. Dysmorphol Clin Genet. 1990;4(1):23\u20136.","journal-title":"Dysmorphol Clin Genet"},{"issue":"1","key":"478_CR36","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1210\/jc.2010-1733","volume":"96","author":"AM Haqq","year":"2011","unstructured":"Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M. The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab. 2011;96(1):E225-232. https:\/\/doi.org\/10.1210\/jc.2010-1733.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"478_CR37","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.numecd.2009.10.004","volume":"21","author":"P Brambilla","year":"2011","unstructured":"Brambilla P, Crino A, Bedogni G, et al. Metabolic syndrome in children with Prader-Willi syndrome: the effect of obesity. Nutr Metab Cardiovasc Dis. 2011;21(4):269\u201376. https:\/\/doi.org\/10.1016\/j.numecd.2009.10.004.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"478_CR38","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/gim.2017.92","volume":"20","author":"AM Manzardo","year":"2018","unstructured":"Manzardo AM, Loker J, Heinemann J, Loker C, Butler MG. Survival trends from the Prader-Willi Syndrome Association (USA) 40-year mortality survey. Genet Med. 2018;20(1):24\u201330. https:\/\/doi.org\/10.1038\/gim.2017.92.","journal-title":"Genet Med"},{"issue":"7","key":"478_CR39","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1017\/S1368980014001542","volume":"18","author":"L Schwingshackl","year":"2015","unstructured":"Schwingshackl L, Missbach B, Konig J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: a systematic review and meta-analysis. Public Health Nutr. 2015;18(7):1292\u20139. https:\/\/doi.org\/10.1017\/S1368980014001542.","journal-title":"Public Health Nutr"},{"issue":"5","key":"478_CR40","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/ajmg.a.31683","volume":"143A","author":"MG Butler","year":"2007","unstructured":"Butler MG, Theodoro M, Skouse JD. Thyroid function studies in Prader-Willi syndrome. Am J Med Genet A. 2007;143A(5):488\u201392. https:\/\/doi.org\/10.1002\/ajmg.a.31683.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"478_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1365-2265.2010.03840.x","volume":"73","author":"E Vaiani","year":"2010","unstructured":"Vaiani E, Herzovich V, Chaler E, et al. Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life. Clin Endocrinol (Oxf). 2010;73(4):546\u201350. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03840.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"478_CR42","doi-asserted-by":"publisher","unstructured":"Pellikaan K, Snijders F, Rosenberg AGW, et al. Thyroid Function in Adults with Prader-Willi Syndrome; a Cohort Study and Literature Review. J Clin Med. 2021;10(17). https:\/\/doi.org\/10.3390\/jcm10173804.","DOI":"10.3390\/jcm10173804"},{"issue":"3","key":"478_CR43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2265.2007.02910.x","volume":"67","author":"DA Festen","year":"2007","unstructured":"Festen DA, Visser TJ, Otten BJ, Wit JM, Duivenvoorden HJ, Hokken-Koelega AC. Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment. Clin Endocrinol (Oxf). 2007;67(3):449\u201356. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02910.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"478_CR44","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1159\/000356927","volume":"81","author":"G Di Giorgio","year":"2014","unstructured":"Di Giorgio G, Grugni G, Fintini D, et al. Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome. Horm Res Paediatr. 2014;81(3):189\u201395. https:\/\/doi.org\/10.1159\/000356927.","journal-title":"Horm Res Paediatr"},{"issue":"10","key":"478_CR45","doi-asserted-by":"publisher","first-page":"4013","DOI":"10.1210\/jc.2013-2012","volume":"98","author":"NE Bakker","year":"2013","unstructured":"Bakker NE, Kuppens RJ, Siemensma EP, et al. Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects. J Clin Endocrinol Metab. 2013;98(10):4013\u201322. https:\/\/doi.org\/10.1210\/jc.2013-2012.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"478_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jpeds.2008.07.058","volume":"154","author":"M Fillion","year":"2009","unstructured":"Fillion M, Deal C, Van Vliet G. Retrospective study of the potential benefits and adverse events during growth hormone treatment in children with Prader-Willi syndrome. J Pediatr. 2009;154(2):230\u20133. https:\/\/doi.org\/10.1016\/j.jpeds.2008.07.058.","journal-title":"J Pediatr"},{"issue":"2","key":"478_CR47","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12020-011-9560-4","volume":"41","author":"R Sode-Carlsen","year":"2012","unstructured":"Sode-Carlsen R, Farholt S, Rabben KF, et al. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study. Endocrine. 2012;41(2):191\u20139. https:\/\/doi.org\/10.1007\/s12020-011-9560-4.","journal-title":"Endocrine"},{"issue":"3","key":"478_CR48","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/ajmg.a.36355","volume":"164A","author":"Y Oto","year":"2014","unstructured":"Oto Y, Tanaka Y, Abe Y, et al. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome. Am J Med Genet A. 2014;164A(3):671\u20135. https:\/\/doi.org\/10.1002\/ajmg.a.36355.","journal-title":"Am J Med Genet A"},{"issue":"5","key":"478_CR49","doi-asserted-by":"publisher","first-page":"R149","DOI":"10.1530\/EJE-20-0363","volume":"183","author":"C Poitou","year":"2020","unstructured":"Poitou C, Mosbah H, Clement K. Mechanisms in Endocrinology: Update on treatments for patients with genetic obesity. Eur J Endocrinol. 2020;183(5):R149\u201366. https:\/\/doi.org\/10.1530\/EJE-20-0363.","journal-title":"Eur J Endocrinol"},{"key":"478_CR50","doi-asserted-by":"publisher","unstructured":"Bellicha A, Coupaye M, Mosbah H, Tauber M, Oppert JM, Poitou C. Physical Activity in Patients with Prader-Willi Syndrome-A Systematic Review of Observational and Interventional Studies. J Clin Med. 2021;10(11). https:\/\/doi.org\/10.3390\/jcm10112528.","DOI":"10.3390\/jcm10112528"},{"issue":"5","key":"478_CR51","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/ajmg.a.31507","volume":"143A","author":"MG Butler","year":"2007","unstructured":"Butler MG, Theodoro MF, Bittel DC, Donnelly JE. Energy expenditure and physical activity in Prader-Willi syndrome: comparison with obese subjects. Am J Med Genet A. 2007;143A(5):449\u201359. https:\/\/doi.org\/10.1002\/ajmg.a.31507.","journal-title":"Am J Med Genet A"},{"issue":"11","key":"478_CR52","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1016\/j.ridd.2014.07.035","volume":"35","author":"DM Castner","year":"2014","unstructured":"Castner DM, Tucker JM, Wilson KS, Rubin DA. Patterns of habitual physical activity in youth with and without Prader-Willi Syndrome. Res Dev Disabil. 2014;35(11):3081\u20138. https:\/\/doi.org\/10.1016\/j.ridd.2014.07.035.","journal-title":"Res Dev Disabil"},{"issue":"24","key":"478_CR53","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1136\/bjsports-2020-102955","volume":"54","author":"FC Bull","year":"2020","unstructured":"Bull FC, Al-Ansari SS, Biddle S, et al. World Health Organization 2020 guidelines on physical activity and sedentary behaviour. Br J Sports Med. 2020;54(24):1451\u201362. https:\/\/doi.org\/10.1136\/bjsports-2020-102955.","journal-title":"Br J Sports Med"},{"issue":"5","key":"478_CR54","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/cen.13953","volume":"90","author":"JS Morales","year":"2019","unstructured":"Morales JS, Valenzuela PL, Pareja-Galeano H, Rincon-Castanedo C, Rubin DA, Lucia A. Physical exercise and Prader-Willi syndrome: A systematic review. Clin Endocrinol (Oxf). 2019;90(5):649\u201361. https:\/\/doi.org\/10.1111\/cen.13953.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"19\u201320","key":"478_CR55","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3109\/09638288.2010.549288","volume":"33","author":"E Grolla","year":"2011","unstructured":"Grolla E, Andrighetto G, Parmigiani P, et al. Specific treatment of Prader-Willi syndrome through cyclical rehabilitation programmes. Disabil Rehabil. 2011;33(19\u201320):1837\u201347. https:\/\/doi.org\/10.3109\/09638288.2010.549288.","journal-title":"Disabil Rehabil"},{"issue":"6","key":"478_CR56","first-page":"654","volume":"97","author":"KH Silverthorn","year":"1993","unstructured":"Silverthorn KH, Hornak JE. Beneficial effects of exercise on aerobic capacity and body composition in adults with Prader-Willi syndrome. Am J Ment Retard. 1993;97(6):654\u20138.","journal-title":"Am J Ment Retard"},{"issue":"2","key":"478_CR57","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/00007611-199502000-00003","volume":"88","author":"H Kaufman","year":"1995","unstructured":"Kaufman H, Overton G, Leggott J, Clericuzio C. Prader-Willi syndrome: effect of group home placement on obese patients with diabetes. South Med J. 1995;88(2):182\u20134.","journal-title":"South Med J"},{"issue":"Suppl 2","key":"478_CR58","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1038\/sj.ejcn.1601426","volume":"56","author":"Biro G, Hulshof KF, Ovesen L, Amorim Cruz JA, Group E","year":"2002","unstructured":"Biro G, Hulshof KF, Ovesen L, Amorim Cruz JA, Group E. Selection of methodology to assess food intake. Eur J Clin Nutr. 2002;56(Suppl 2):S25-32. https:\/\/doi.org\/10.1038\/sj.ejcn.1601426.","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"478_CR59","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1017\/S0029665116003025","volume":"76","author":"J Conrad","year":"2017","unstructured":"Conrad J, Nothlings U. Innovative approaches to estimate individual usual dietary intake in large-scale epidemiological studies. Proc Nutr Soc. 2017;76(3):213\u20139. https:\/\/doi.org\/10.1017\/S0029665116003025.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"478_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/jhn.12278","volume":"29","author":"AM Madden","year":"2016","unstructured":"Madden AM, Smith S. Body composition and morphological assessment of nutritional status in adults: a review of anthropometric variables. J Hum Nutr Diet. 2016;29(1):7\u201325. https:\/\/doi.org\/10.1111\/jhn.12278.","journal-title":"J Hum Nutr Diet"},{"issue":"4","key":"478_CR61","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","volume":"3","author":"SS Khan","year":"2018","unstructured":"Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018;3(4):280\u20137. https:\/\/doi.org\/10.1001\/jamacardio.2018.0022.","journal-title":"JAMA Cardiol"},{"issue":"3","key":"478_CR62","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","volume":"16","author":"R Ross","year":"2020","unstructured":"Ross R, Neeland IJ, Yamashita S, et al. Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity. Nat Rev Endocrinol. 2020;16(3):177\u201389. https:\/\/doi.org\/10.1038\/s41574-019-0310-7.","journal-title":"Nat Rev Endocrinol"},{"key":"478_CR63","unstructured":"Centers for Disease Control and Prevention (CDC). The National Health and Nutrition Examination Survey. Anthropometry Procedures Manual.\u00a0https:\/\/www.cdc.gov\/nchs\/data\/nhanes\/nhanes_11_12\/Anthropometry_Procedures_Manual.pdf. Accessed 21 Dec\u00a02021."},{"key":"478_CR64","doi-asserted-by":"publisher","unstructured":"Riccardi G, Aggett P, Brighenti F, et al. Passclaim--body weight regulation, insulin sensitivity and diabetes risk. Eur J Nutr. 2004;43 Suppl 2:II7-II46. https:\/\/doi.org\/10.1007\/s00394-004-1202-7.","DOI":"10.1007\/s00394-004-1202-7"},{"issue":"2","key":"478_CR65","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3109\/08941939.2013.832824","volume":"27","author":"M Musella","year":"2014","unstructured":"Musella M, Milone M, Leongito M, Maietta P, Bianco P, Pisapia A. The mini-gastric bypass in the management of morbid obesity in Prader-Willi syndrome: a viable option? J Invest Surg. 2014;27(2):102\u20135. https:\/\/doi.org\/10.3109\/08941939.2013.832824.","journal-title":"J Invest Surg"},{"issue":"6","key":"478_CR66","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1111\/jhn.12372","volume":"29","author":"S Smith","year":"2016","unstructured":"Smith S, Madden AM. Body composition and functional assessment of nutritional status in adults: a narrative review of imaging, impedance, strength and functional techniques. J Hum Nutr Diet. 2016;29(6):714\u201332. https:\/\/doi.org\/10.1111\/jhn.12372.","journal-title":"J Hum Nutr Diet"},{"key":"478_CR67","doi-asserted-by":"publisher","unstructured":"Barrea L, Muscogiuri G, Pugliese G, et al. The Sun's Vitamin in Adult Patients Affected by Prader-Willi Syndrome. Nutrients. 2020;12(4). https:\/\/doi.org\/10.3390\/nu12041132.","DOI":"10.3390\/nu12041132"},{"key":"478_CR68","doi-asserted-by":"publisher","unstructured":"Woods SG, Knehans A, Arnold S, et al. The associations between diet and physical activity with body composition and walking a timed distance in adults with Prader-Willi syndrome. Food Nutr Res. 2018;62. https:\/\/doi.org\/10.29219\/fnr.v62.1343.","DOI":"10.29219\/fnr.v62.1343"},{"key":"478_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.appet.2015.12.021","volume":"99","author":"L Martinez Michel","year":"2016","unstructured":"Martinez Michel L, Haqq AM, Wismer WV. A review of chemosensory perceptions, food preferences and food-related behaviours in subjects with Prader-Willi Syndrome. Appetite. 2016;99:17\u201324. https:\/\/doi.org\/10.1016\/j.appet.2015.12.021.","journal-title":"Appetite"},{"issue":"6","key":"478_CR70","doi-asserted-by":"publisher","first-page":"538","DOI":"10.3109\/03014460.2014.990922","volume":"42","author":"G Bedogni","year":"2015","unstructured":"Bedogni G, Grugni G, Tringali G, Agosti F, Sartorio A. Assessment of fat-free mass from bioelectrical impedance analysis in obese women with Prader-Willi syndrome. Ann Hum Biol. 2015;42(6):538\u201342. https:\/\/doi.org\/10.3109\/03014460.2014.990922.","journal-title":"Ann Hum Biol"},{"issue":"11","key":"478_CR71","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jfma.2011.09.010","volume":"110","author":"HY Lin","year":"2011","unstructured":"Lin HY, Chen MR, Chuang CK, Huang CY, Niu DM, Lin SP. Assessment of body composition using bioelectrical impedance analysis in Prader-Willi syndrome. J Formos Med Assoc. 2011;110(11):719\u201323. https:\/\/doi.org\/10.1016\/j.jfma.2011.09.010.","journal-title":"J Formos Med Assoc"},{"issue":"1","key":"478_CR72","first-page":"27","volume":"4","author":"JO Hill","year":"1990","unstructured":"Hill JO, Kaler M, Spetalnick B, Reed G, Butler MG. Resting Metabolic Rate in Prader-Willi Syndrome. Dysmorphol Clin Genet. 1990;4(1):27\u201332.","journal-title":"Dysmorphol Clin Genet"},{"issue":"4","key":"478_CR73","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/ejcn.2015.161","volume":"70","author":"S Lazzer","year":"2016","unstructured":"Lazzer S, Grugni G, Tringali G, Sartorio A. Prediction of basal metabolic rate in patients with Prader-Willi syndrome. Eur J Clin Nutr. 2016;70(4):494\u20138. https:\/\/doi.org\/10.1038\/ejcn.2015.161.","journal-title":"Eur J Clin Nutr"},{"key":"478_CR74","doi-asserted-by":"publisher","unstructured":"Saeed N, Nadeau B, Shannon C, Tincopa M. Evaluation of Dietary Approaches for the Treatment of Non-Alcoholic Fatty Liver Disease: A Systematic Review. Nutrients. 2019;11(12). https:\/\/doi.org\/10.3390\/nu11123064.","DOI":"10.3390\/nu11123064"},{"key":"478_CR75","doi-asserted-by":"publisher","unstructured":"Ditano-Vazquez P, Torres-Pena JD, Galeano-Valle F, et al. The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil. Nutrients. 2019;11(11). https:\/\/doi.org\/10.3390\/nu11112833.","DOI":"10.3390\/nu11112833"},{"issue":"2","key":"478_CR76","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/s0026-0495(98)90003-8","volume":"37","author":"DA Schoeller","year":"1988","unstructured":"Schoeller DA, Levitsky LL, Bandini LG, Dietz WW, Walczak A. Energy expenditure and body composition in Prader-Willi syndrome. Metabolism. 1988;37(2):115\u201320. https:\/\/doi.org\/10.1016\/s0026-0495(98)90003-8.","journal-title":"Metabolism"},{"issue":"1","key":"478_CR77","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111\u201388. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455.","journal-title":"Eur Heart J"},{"key":"478_CR78","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.freeradbiomed.2021.09.018","volume":"176","author":"M Siervo","year":"2021","unstructured":"Siervo M, Shannon OM, Llewellyn DJ, Stephan BC, Fontana L. Mediterranean diet and cognitive function: From methodology to mechanisms of action. Free Radic Biol Med. 2021;176:105\u201317. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.09.018.","journal-title":"Free Radic Biol Med"},{"key":"478_CR79","doi-asserted-by":"publisher","unstructured":"Barrea L, Muscogiuri G, Pugliese G, et al. Phase Angle as an Easy Diagnostic Tool of Meta-Inflammation for the Nutritionist. Nutrients. 2021;13(5). https:\/\/doi.org\/10.3390\/nu13051446.","DOI":"10.3390\/nu13051446"},{"key":"478_CR80","doi-asserted-by":"publisher","unstructured":"Barrea L, Pugliese G, de Alteriis G, Colao A, Savastano S, Muscogiuri G. Phase Angle: Could Be an Easy Tool to Detect Low-Grade Systemic Inflammation in Adults Affected by Prader-Willi Syndrome? Nutrients. 2020;12(7). https:\/\/doi.org\/10.3390\/nu12072065.","DOI":"10.3390\/nu12072065"},{"issue":"8","key":"478_CR81","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1017\/S0007114511004028","volume":"107","author":"N Stobaus","year":"2012","unstructured":"Stobaus N, Pirlich M, Valentini L, Schulzke JD, Norman K. Determinants of bioelectrical phase angle in disease. Br J Nutr. 2012;107(8):1217\u201320. https:\/\/doi.org\/10.1017\/S0007114511004028.","journal-title":"Br J Nutr"},{"issue":"4","key":"478_CR82","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/01.gim.0000204469.30913.67","volume":"8","author":"MG Butler","year":"2006","unstructured":"Butler MG, Bittel DC, Kibiryeva N, Garg U. C-reactive protein levels in subjects with Prader-Willi syndrome and obesity. Genet Med. 2006;8(4):243\u20138. https:\/\/doi.org\/10.1097\/01.gim.0000204469.30913.67.","journal-title":"Genet Med"},{"issue":"2","key":"478_CR83","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF03345585","volume":"31","author":"A Caixas","year":"2008","unstructured":"Caixas A, Gimenez-Palop O, Broch M, et al. Adult subjects with Prader-Willi syndrome show more low-grade systemic inflammation than matched obese subjects. J Endocrinol Invest. 2008;31(2):169\u201375. https:\/\/doi.org\/10.1007\/BF03345585.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"478_CR84","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000093229","volume":"66","author":"C Hoybye","year":"2006","unstructured":"Hoybye C. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment. Horm Res. 2006;66(1):27\u201332. https:\/\/doi.org\/10.1159\/000093229.","journal-title":"Horm Res"},{"issue":"1","key":"478_CR85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/j.1365-277X.2012.01275.x","volume":"26","author":"JL Miller","year":"2013","unstructured":"Miller JL, Lynn CH, Shuster J, Driscoll DJ. A reduced-energy intake, well-balanced diet improves weight control in children with Prader-Willi syndrome. J Hum Nutr Diet. 2013;26(1):2\u20139. https:\/\/doi.org\/10.1111\/j.1365-277X.2012.01275.x.","journal-title":"J Hum Nutr Diet"},{"issue":"4","key":"478_CR86","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/cen.13933","volume":"90","author":"KA Irizarry","year":"2019","unstructured":"Irizarry KA, Mager DR, Triador L, Muehlbauer MJ, Haqq AM, Freemark M. Hormonal and metabolic effects of carbohydrate restriction in children with Prader-Willi syndrome. Clin Endocrinol (Oxf). 2019;90(4):553\u201361. https:\/\/doi.org\/10.1111\/cen.13933.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"478_CR87","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s13023-020-01412-w","volume":"15","author":"G Felix","year":"2020","unstructured":"Felix G, Kossoff E, Barron B, Krekel C, Testa EG, Scheimann A. The modified Atkins diet in children with Prader-Willi syndrome. Orphanet J Rare Dis. 2020;15(1):135. https:\/\/doi.org\/10.1186\/s13023-020-01412-w.","journal-title":"Orphanet J Rare Dis"},{"key":"478_CR88","doi-asserted-by":"publisher","unstructured":"Bedogni G, Grugni G, Cicolini S, Caroli D, Tamini S, Sartorio A. Changes of Body Weight and Body Composition in Obese Patients with Prader-Willi Syndrome at 3 and 6 Years of Follow-Up: A Retrospective Cohort Study. J Clin Med. 2020;9(11). https:\/\/doi.org\/10.3390\/jcm9113596.","DOI":"10.3390\/jcm9113596"},{"key":"478_CR89","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2147\/AHMT.S214893","volume":"11","author":"JL Miller","year":"2020","unstructured":"Miller JL, Tan M. Dietary Management for Adolescents with Prader-Willi Syndrome. Adolesc Health Med Ther. 2020;11:113\u20138. https:\/\/doi.org\/10.2147\/AHMT.S214893.","journal-title":"Adolesc Health Med Ther"},{"key":"478_CR90","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1100\/tsw.2009.105","volume":"9","author":"W Bonfig","year":"2009","unstructured":"Bonfig W, Dokoupil K, Schmidt H. A special, strict, fat-reduced, and carbohydrate-modified diet leads to marked weight reduction even in overweight adolescents with Prader-Willi syndrome (PWS). ScientificWorldJournal. 2009;9:934\u20139. https:\/\/doi.org\/10.1100\/tsw.2009.105.","journal-title":"ScientificWorldJournal"},{"issue":"7","key":"478_CR91","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1515\/JPEM.2008.21.7.651","volume":"21","author":"H Schmidt","year":"2008","unstructured":"Schmidt H, Pozza SB, Bonfig W, Schwarz HP, Dokoupil K. Successful early dietary intervention avoids obesity in patients with Prader-Willi syndrome: a ten-year follow-up. J Pediatr Endocrinol Metab. 2008;21(7):651\u20135. https:\/\/doi.org\/10.1515\/JPEM.2008.21.7.651.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"478_CR92","doi-asserted-by":"publisher","first-page":"873","DOI":"10.2147\/TCRM.S70068","volume":"12","author":"G Grugni","year":"2016","unstructured":"Grugni G, Sartorio A, Crino A. Growth hormone therapy for Prader-willi syndrome: challenges and solutions. Ther Clin Risk Manag. 2016;12:873\u201381. https:\/\/doi.org\/10.2147\/TCRM.S70068.","journal-title":"Ther Clin Risk Manag"},{"issue":"11","key":"478_CR93","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1111\/j.1651-2227.2010.01904.x","volume":"99","author":"I Sipila","year":"2010","unstructured":"Sipila I, Sintonen H, Hietanen H, et al. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome. Acta Paediatr. 2010;99(11):1712\u20138. https:\/\/doi.org\/10.1111\/j.1651-2227.2010.01904.x.","journal-title":"Acta Paediatr"},{"issue":"11","key":"478_CR94","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ncpendmet0320","volume":"2","author":"MG Butler","year":"2006","unstructured":"Butler MG. Management of obesity in Prader-Willi syndrome. Nat Clin Pract Endocrinol Metab. 2006;2(11):592\u20133. https:\/\/doi.org\/10.1038\/ncpendmet0320.","journal-title":"Nat Clin Pract Endocrinol Metab"},{"issue":"1","key":"478_CR95","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41398-019-0597-0","volume":"9","author":"A Consoli","year":"2019","unstructured":"Consoli A, Cabal Berthoumieu S, Raffin M, et al. Effect of topiramate on eating behaviours in Prader-Willi syndrome: TOPRADER double-blind randomised placebo-controlled study. Transl Psychiatry. 2019;9(1):274. https:\/\/doi.org\/10.1038\/s41398-019-0597-0.","journal-title":"Transl Psychiatry"},{"issue":"1","key":"478_CR96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1586\/17512433.2016.1100072","volume":"9","author":"KF Ali","year":"2016","unstructured":"Ali KF, Shukla AP, Aronne LJ. Bupropion-SR plus naltrexone-SR for the treatment of mild-to-moderate obesity. Expert Rev Clin Pharmacol. 2016;9(1):27\u201334. https:\/\/doi.org\/10.1586\/17512433.2016.1100072.","journal-title":"Expert Rev Clin Pharmacol"},{"key":"478_CR97","doi-asserted-by":"publisher","unstructured":"Barrea L, Pugliese G, Muscogiuri G, Laudisio D, Colao A, Savastano S. New-generation anti-obesity drugs: naltrexone\/bupropion and liraglutide. An update for endocrinologists and nutritionists. Minerva Endocrinol. 2020;45(2):127\u2013137. https:\/\/doi.org\/10.23736\/S0391-1977.20.03179-X.","DOI":"10.23736\/S0391-1977.20.03179-X"},{"key":"478_CR98","doi-asserted-by":"publisher","unstructured":"Bueno M, Boixadera-Planas E, Blanco-Hinojo L, et al. Hunger and Satiety Peptides: Is There a Pattern to Classify Patients with Prader-Willi Syndrome? J Clin Med. 2021;10(21). https:\/\/doi.org\/10.3390\/jcm10215170.","DOI":"10.3390\/jcm10215170"},{"issue":"7","key":"478_CR99","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/cmdc.201700781","volume":"13","author":"JY Cheang","year":"2018","unstructured":"Cheang JY, Moyle PM. Glucagon-Like Peptide-1 (GLP-1)-Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes. ChemMedChem. 2018;13(7):662\u201371. https:\/\/doi.org\/10.1002\/cmdc.201700781.","journal-title":"ChemMedChem"},{"issue":"3","key":"478_CR100","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/ijpo.12131","volume":"12","author":"P Salehi","year":"2017","unstructured":"Salehi P, Hsu I, Azen CG, Mittelman SD, Geffner ME, Jeandron D. Effects of exenatide on weight and appetite in overweight adolescents and young adults with Prader-Willi syndrome. Pediatr Obes. 2017;12(3):221\u20138. https:\/\/doi.org\/10.1111\/ijpo.12131.","journal-title":"Pediatr Obes"},{"issue":"1","key":"478_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0190849","volume":"13","author":"S Allas","year":"2018","unstructured":"Allas S, Caixas A, Poitou C, et al. AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: A randomized placebo-controlled trial. PLoS ONE. 2018;13(1): e0190849. https:\/\/doi.org\/10.1371\/journal.pone.0190849.","journal-title":"PLoS ONE"},{"key":"478_CR102","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/B978-0-12-820683-6.00026-9","volume":"181","author":"M Tauber","year":"2021","unstructured":"Tauber M, Diene G. Prader-Willi syndrome: Hormone therapies. Handb Clin Neurol. 2021;181:351\u201367. https:\/\/doi.org\/10.1016\/B978-0-12-820683-6.00026-9.","journal-title":"Handb Clin Neurol"},{"issue":"11","key":"478_CR103","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1007\/s11695-020-04708-9","volume":"30","author":"M Tripodi","year":"2020","unstructured":"Tripodi M, Casertano A, Peluso M, et al. Prader-Willi Syndrome: Role of Bariatric Surgery in Two Adolescents with Obesity. Obes Surg. 2020;30(11):4602\u20134. https:\/\/doi.org\/10.1007\/s11695-020-04708-9.","journal-title":"Obes Surg"},{"issue":"1","key":"478_CR104","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/01.mpg.0000304458.30294.31","volume":"46","author":"AO Scheimann","year":"2008","unstructured":"Scheimann AO, Butler MG, Gourash L, Cuffari C, Klish W. Critical analysis of bariatric procedures in Prader-Willi syndrome. J Pediatr Gastroenterol Nutr. 2008;46(1):80\u20133. https:\/\/doi.org\/10.1097\/01.mpg.0000304458.30294.31.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"1","key":"478_CR105","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.soard.2015.07.014","volume":"12","author":"AR Alqahtani","year":"2016","unstructured":"Alqahtani AR, Elahmedi MO, Al Qahtani AR, Lee J, Butler MG. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched-control study. Surg Obes Relat Dis. 2016;12(1):100\u201310. https:\/\/doi.org\/10.1016\/j.soard.2015.07.014.","journal-title":"Surg Obes Relat Dis"},{"issue":"11","key":"478_CR106","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1007\/s11695-012-0725-x","volume":"22","author":"AK Fong","year":"2012","unstructured":"Fong AK, Wong SK, Lam CC, Ng EK. Ghrelin level and weight loss after laparoscopic sleeve gastrectomy and gastric mini-bypass for Prader-Willi syndrome in Chinese. Obes Surg. 2012;22(11):1742\u20135. https:\/\/doi.org\/10.1007\/s11695-012-0725-x.","journal-title":"Obes Surg"},{"issue":"2","key":"478_CR107","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.soard.2016.08.013","volume":"13","author":"AO Scheimann","year":"2017","unstructured":"Scheimann AO, Miller J, Glaze DG. Laparoscopic sleeve gastrectomy in children and adolescents with Prader-Willi syndrome: a matched control study. Surg Obes Relat Dis. 2017;13(2):366. https:\/\/doi.org\/10.1016\/j.soard.2016.08.013.","journal-title":"Surg Obes Relat Dis"},{"issue":"1","key":"478_CR108","doi-asserted-by":"publisher","DOI":"10.1111\/ijpo.12575","volume":"15","author":"SY Liu","year":"2020","unstructured":"Liu SY, Wong SK, Lam CC, Ng EK. Bariatric surgery for Prader-Willi syndrome was ineffective in producing sustainable weight loss: Long term results for up to 10 years. Pediatr Obes. 2020;15(1): e12575. https:\/\/doi.org\/10.1111\/ijpo.12575.","journal-title":"Pediatr Obes"},{"issue":"11","key":"478_CR109","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1136\/medethics-2019-106038","volume":"46","author":"ML Di Pietro","year":"2020","unstructured":"Di Pietro ML, Zace D. Three scenarios illustrating ethical concerns when considering bariatric surgery in obese adolescents with Prader-Willi syndrome. J Med Ethics. 2020;46(11):738\u201342. https:\/\/doi.org\/10.1136\/medethics-2019-106038.","journal-title":"J Med Ethics"}],"container-title":["Current Obesity Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-022-00478-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13679-022-00478-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13679-022-00478-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T09:47:25Z","timestamp":1670406445000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13679-022-00478-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,5]]},"references-count":109,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["478"],"URL":"https:\/\/doi.org\/10.1007\/s13679-022-00478-w","relation":{},"ISSN":["2162-4968"],"issn-type":[{"value":"2162-4968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,5]]},"assertion":[{"value":"23 June 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}